A Practical and Scalable Manufacturing Process for an Antifungal Agent, Nikkomycin Z-Reference-Cited by-同舟云学术

A Practical and Scalable Manufacturing Process for an Antifungal Agent, Nikkomycin Z

Published:2013-01-17 Issue:2 Volume:17 Page:265-272
ISSN:1083-6160
Container-title:Organic Process Research & Development
language:en
Short-container-title:Org. Process Res. Dev.

Author:

Stenland Christopher J.¹²,Lis Lev G.¹²,Schendel Frederick J.¹²,Hahn Nicholas J.¹²,Smart Mary A.¹²,Miller Amy L.¹²,von Keitz Marc G.¹²,Gurvich Vadim J.¹²

Affiliation:

1. Institute for Therapeutics Discovery and Development and Department of Medicinal Chemistry, University of Minnesota, Minneapolis, Minnesota 55414, United States

2. BioTechnology Institute, University of Minnesota, Saint Paul, Minnesota 55108, United States

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Physical and Theoretical Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/op3003294

Reference31 articles.

1. Nikkomycins: Microbial inhibitors of chitin synthase

2. A comparison of the chitin synthase-inhibitory and antifungal efficacy of nucleoside-peptide antibiotics: structure-activity relationships

3. Structure-activity relationships of the nikkomycins

4. Metabolic products of microorganisms

5. Importance of antifungal drug-resistance: clinical significance and need for novel therapy

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Insights into Fungal Infections Prophylaxis and Treatment in Pediatric Patients with Cancer;Antibiotics;2022-09-27

2. Modulating chitin synthesis in marine algae with iminosugars obtained by SmI₂ and FeCl₃-mediated diastereoselective carbonyl ene reaction;Organic & Biomolecular Chemistry;2022

3. Potent antifungal agents and use of nanocarriers to improve delivery to the infected site: A systematic review;Journal of Basic Microbiology;2021-08-17

4. Microbes to Man: From Soils and the Depths to Drugs;Burger's Medicinal Chemistry and Drug Discovery;2021-04-26

5. Natural products and derivatives as human drugs;Remington;2021